Why the study?
The coexistence of cardiac myxoma and antiphospholipid syndrome is rarely described in the literature.
Highlights the rare coexistence of left atrial myxoma and antiphospholipid syndrome, emphasizing the need for multimodality imaging to differentiate from atrial thrombus.
May prompt APS consideration in myxoma-related stroke; leaves open need for systematic studies on prevalence and causality.
Cardiac myxoma (CM) is the most frequent type of primary cardiac neoplasm and is responsible for 58 to 80% of primary cardiac tumors. The antiphospholipid syndrome (APS) occurs most commonly in the systemic lupus erythematosus but it can be also found in other conditions. The coexistence of CM and APS is rarely described in the literature. We report an unusual case of the left atrial myxoma and concomitant APS in a female patient who presented with right-sided hemiplegia. Although rare, we must think about the CM in patients with a newly diagnosed APS and left atrial mass. Nevertheless, we must make a distinction from other possible cardiac structures, especially atrial thrombus. Transthoracic echocardiography is the most frequently used initial imaging modality to detect CM. The aim of this case report was to emphasize that additional imaging modalities and multidisciplinary approach are mandatory in making a proper diagnosis and to choose a further treatment strategy.
No takes yet. Share an insight, caveat, or question.
Meter et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: